Life (in years)  
Aggregate 
Intrinsic Value 
As of December 31, 2023   123    12,641   $ 20.03   2.79  $ 535  
Granted   —    3,009   $ 62.72      
Exercised   (90)    (7,909)   $ 16.90      
Canceled and forfeited   —    (543)   $ 32.19      
As of December 31, 2024   33    7,198   $ 40.16   4.90  $ 153  
Exercisable as of December 31, 2024   33    3,484   $ 22.03   3.16  $ 135  
The total intrinsic value of stock options and SARs exercised for the years ended December 31, 2022, 2023 and 2024, was 
$101 million, $319 million, and $433 million respectively. 
RSU Activity 
The following table summarizes the activity related to our RSUs for the year ended December 31, 2024 (in thousands, except 
per share amounts): 
  Number of Shares  
Weighted-Average 
 Grant-Date Fair 
 Value per Share 
Unvested and outstanding as of December 31, 2023   90,827   $ 34.49  
Granted   28,750   $ 74.87  
Vested   (43,285)   $ 38.76  
Canceled and forfeited   (10,090)   $ 40.89  
Unvested and outstanding as of December 31, 2024   66,202   $ 48.49   
112 
The total fair value of RSUs vested for the years ended December 31, 2022, 2023 and 2024 was $1.8 billion, $1.7 billion, and 
$1.7 billion, respectively. 
Restricted Common Stock 
We have granted restricted common stock to certain continuing employees, primarily in connection with acquisitions.